Rep. Paul Gosar Introduces Bill to End Vaccine Manufacturer Immunity From Injury Lawsuits

WASHINGTON, D.C. (LifeSiteNews) — Republican U.S. Rep. Paul Gosar of Arizona introduced a bill Thursday that would end pharmaceutical companies’ shield against liability for any potential harmful effects of the vaccines they manufacture.

H.R. 9828, the End the Vaccine Carveout Act, would allow individuals to “bring a civil action against a vaccine administrator or manufacturer in a State or Federal court for damages arising from such injury or death,” according to an advance copy of the text provided to LifeSiteNews.

This would eliminate the general immunity vaccine manufacturers enjoy under the federal National Childhood Vaccine Injury Act of 1986, which instead establishes a compensation program for victims. Gosar’s bill allows for civil actions to be pursued regardless of whether a victim has filed a petition with the program, although ultimately receiving an award from one would invalidate a petition to the other.

“Government bureaucrats and scientists responsible for approving vaccines are in bed with Big Pharma, often owning pharmaceutical stocks, serving as consultants and receiving lucrative contracts from pharmaceutical companies that pressure them to produce favorable results which is in direct violation of federal law,” Gosar said in a press release. “Big Pharma doesn’t deserve a get-out-of-jail-free card for injuries caused by their harmful vaccines.”

The question of vaccine safety has become more mainstream in recent years due to the controversy surrounding the COVID-19 vaccines, which were developed and reviewed in a fraction of the time vaccines usually take under the Trump administration’s Operation Warp Speed initiative.

A large body of evidence identifies significant risks to the COVID vaccines. Among it, the federal Vaccine Adverse Event Reporting System (VAERS) reports 37,910 deaths, 217,931 hospitalizations, 21,917 heart attacks, and 28,602 myocarditis and pericarditis cases as of September 6, among other ailments. U.S. Centers for Disease Control and Prevention (CDC) researchers have recognized a “high verification rate of reports of myocarditis to VAERS after mRNA-based COVID-19 vaccination,” leading to the conclusion that “under-reporting is more likely” than over-reporting. […]

— Read More: www.lifesitenews.com